nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—AR—hematologic cancer	0.301	1	CbGaD
Bicalutamide—CYP2C9—Bexarotene—hematologic cancer	0.0209	0.049	CbGbCtD
Bicalutamide—CYP2D6—Lomustine—hematologic cancer	0.0178	0.0416	CbGbCtD
Bicalutamide—CYP2C9—Idarubicin—hematologic cancer	0.0173	0.0406	CbGbCtD
Bicalutamide—CYP2D6—Idarubicin—hematologic cancer	0.0159	0.0371	CbGbCtD
Bicalutamide—CYP2C19—Bortezomib—hematologic cancer	0.0154	0.0361	CbGbCtD
Bicalutamide—CYP2D6—Hydroxyurea—hematologic cancer	0.0135	0.0315	CbGbCtD
Bicalutamide—CYP2C19—Thalidomide—hematologic cancer	0.0134	0.0315	CbGbCtD
Bicalutamide—CYP2C9—Bortezomib—hematologic cancer	0.0128	0.03	CbGbCtD
Bicalutamide—CYP2C19—Teniposide—hematologic cancer	0.0128	0.03	CbGbCtD
Bicalutamide—CYP3A4—Bexarotene—hematologic cancer	0.0122	0.0285	CbGbCtD
Bicalutamide—CYP2C19—Ifosfamide—hematologic cancer	0.0118	0.0277	CbGbCtD
Bicalutamide—CYP2D6—Bortezomib—hematologic cancer	0.0117	0.0274	CbGbCtD
Bicalutamide—CYP3A4—Busulfan—hematologic cancer	0.0113	0.0265	CbGbCtD
Bicalutamide—CYP3A4—Lomustine—hematologic cancer	0.0113	0.0265	CbGbCtD
Bicalutamide—CYP2C19—Imatinib—hematologic cancer	0.0113	0.0265	CbGbCtD
Bicalutamide—CYP2C9—Thalidomide—hematologic cancer	0.0112	0.0261	CbGbCtD
Bicalutamide—CYP2C9—Teniposide—hematologic cancer	0.0107	0.0249	CbGbCtD
Bicalutamide—CYP3A4—Thiotepa—hematologic cancer	0.0101	0.0236	CbGbCtD
Bicalutamide—CYP2C9—Ifosfamide—hematologic cancer	0.00984	0.023	CbGbCtD
Bicalutamide—CYP2C9—Imatinib—hematologic cancer	0.0094	0.022	CbGbCtD
Bicalutamide—CYP2D6—Imatinib—hematologic cancer	0.00859	0.0201	CbGbCtD
Bicalutamide—CYP2C9—Nilotinib—hematologic cancer	0.00854	0.02	CbGbCtD
Bicalutamide—CYP3A4—Methoxsalen—hematologic cancer	0.00784	0.0183	CbGbCtD
Bicalutamide—CYP2D6—Nilotinib—hematologic cancer	0.00781	0.0183	CbGbCtD
Bicalutamide—CYP2D6—Vinorelbine—hematologic cancer	0.00774	0.0181	CbGbCtD
Bicalutamide—CYP3A4—Bortezomib—hematologic cancer	0.00746	0.0175	CbGbCtD
Bicalutamide—CYP2C19—Prednisone—hematologic cancer	0.00745	0.0174	CbGbCtD
Bicalutamide—CYP3A4—Daunorubicin—hematologic cancer	0.00713	0.0167	CbGbCtD
Bicalutamide—CYP3A4—Cytarabine—hematologic cancer	0.00629	0.0147	CbGbCtD
Bicalutamide—CYP3A4—Teniposide—hematologic cancer	0.0062	0.0145	CbGbCtD
Bicalutamide—CYP3A4—Ifosfamide—hematologic cancer	0.00572	0.0134	CbGbCtD
Bicalutamide—CYP3A4—Imatinib—hematologic cancer	0.00547	0.0128	CbGbCtD
Bicalutamide—CYP3A4—Ruxolitinib—hematologic cancer	0.00515	0.012	CbGbCtD
Bicalutamide—CYP3A4—Nilotinib—hematologic cancer	0.00497	0.0116	CbGbCtD
Bicalutamide—CYP3A4—Vinorelbine—hematologic cancer	0.00492	0.0115	CbGbCtD
Bicalutamide—CYP2C9—Cisplatin—hematologic cancer	0.00479	0.0112	CbGbCtD
Bicalutamide—CYP2D6—Vinblastine—hematologic cancer	0.00477	0.0112	CbGbCtD
Bicalutamide—CYP2C19—Dexamethasone—hematologic cancer	0.00465	0.0109	CbGbCtD
Bicalutamide—CYP3A4—Triamcinolone—hematologic cancer	0.0045	0.0105	CbGbCtD
Bicalutamide—CYP3A4—Dasatinib—hematologic cancer	0.00439	0.0103	CbGbCtD
Bicalutamide—CYP3A4—Mitoxantrone—hematologic cancer	0.00434	0.0101	CbGbCtD
Bicalutamide—CYP2C9—Dexamethasone—hematologic cancer	0.00387	0.00905	CbGbCtD
Bicalutamide—CYP3A4—Betamethasone—hematologic cancer	0.00386	0.00904	CbGbCtD
Bicalutamide—CYP3A4—Prednisolone—hematologic cancer	0.00381	0.00892	CbGbCtD
Bicalutamide—CYP3A4—Prednisone—hematologic cancer	0.0036	0.00842	CbGbCtD
Bicalutamide—CYP2D6—Dexamethasone—hematologic cancer	0.00354	0.00827	CbGbCtD
Bicalutamide—CYP3A4—Irinotecan—hematologic cancer	0.00341	0.00799	CbGbCtD
Bicalutamide—CYP3A4—Vinblastine—hematologic cancer	0.00303	0.0071	CbGbCtD
Bicalutamide—CYP3A4—Vincristine—hematologic cancer	0.00298	0.00698	CbGbCtD
Bicalutamide—CYP2D6—Doxorubicin—hematologic cancer	0.00293	0.00686	CbGbCtD
Bicalutamide—CYP3A4—Etoposide—hematologic cancer	0.00273	0.0064	CbGbCtD
Bicalutamide—CYP3A4—Dexamethasone—hematologic cancer	0.00225	0.00526	CbGbCtD
Bicalutamide—CYP3A4—Doxorubicin—hematologic cancer	0.00186	0.00436	CbGbCtD
Bicalutamide—Enzalutamide—AR—hematologic cancer	0.00146	0.599	CrCbGaD
Bicalutamide—Enzalutamide—ALB—hematologic cancer	0.0005	0.205	CrCbGaD
Bicalutamide—Enzalutamide—ABCB1—hematologic cancer	0.000477	0.196	CrCbGaD
Bicalutamide—Angiopathy—Epirubicin—hematologic cancer	1.72e-05	7.59e-05	CcSEcCtD
Bicalutamide—Urethral disorder—Doxorubicin—hematologic cancer	1.72e-05	7.58e-05	CcSEcCtD
Bicalutamide—Decreased appetite—Betamethasone—hematologic cancer	1.72e-05	7.58e-05	CcSEcCtD
Bicalutamide—Decreased appetite—Dexamethasone—hematologic cancer	1.72e-05	7.58e-05	CcSEcCtD
Bicalutamide—Nausea—Mitoxantrone—hematologic cancer	1.72e-05	7.57e-05	CcSEcCtD
Bicalutamide—Nausea—Irinotecan—hematologic cancer	1.72e-05	7.57e-05	CcSEcCtD
Bicalutamide—Immune system disorder—Epirubicin—hematologic cancer	1.72e-05	7.55e-05	CcSEcCtD
Bicalutamide—Infection—Prednisone—hematologic cancer	1.71e-05	7.54e-05	CcSEcCtD
Bicalutamide—Mediastinal disorder—Epirubicin—hematologic cancer	1.71e-05	7.53e-05	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.71e-05	7.53e-05	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.71e-05	7.53e-05	CcSEcCtD
Bicalutamide—Back pain—Methotrexate—hematologic cancer	1.71e-05	7.52e-05	CcSEcCtD
Bicalutamide—Fatigue—Dexamethasone—hematologic cancer	1.71e-05	7.52e-05	CcSEcCtD
Bicalutamide—Fatigue—Betamethasone—hematologic cancer	1.71e-05	7.52e-05	CcSEcCtD
Bicalutamide—Chills—Epirubicin—hematologic cancer	1.7e-05	7.5e-05	CcSEcCtD
Bicalutamide—Pruritus—Etoposide—hematologic cancer	1.7e-05	7.5e-05	CcSEcCtD
Bicalutamide—Shock—Prednisone—hematologic cancer	1.7e-05	7.47e-05	CcSEcCtD
Bicalutamide—Arrhythmia—Epirubicin—hematologic cancer	1.7e-05	7.47e-05	CcSEcCtD
Bicalutamide—Pain—Betamethasone—hematologic cancer	1.69e-05	7.46e-05	CcSEcCtD
Bicalutamide—Pain—Dexamethasone—hematologic cancer	1.69e-05	7.46e-05	CcSEcCtD
Bicalutamide—Visual impairment—Doxorubicin—hematologic cancer	1.69e-05	7.45e-05	CcSEcCtD
Bicalutamide—Nervous system disorder—Prednisone—hematologic cancer	1.69e-05	7.45e-05	CcSEcCtD
Bicalutamide—Alopecia—Epirubicin—hematologic cancer	1.68e-05	7.39e-05	CcSEcCtD
Bicalutamide—Skin disorder—Prednisone—hematologic cancer	1.68e-05	7.38e-05	CcSEcCtD
Bicalutamide—Nausea—Gemcitabine—hematologic cancer	1.67e-05	7.37e-05	CcSEcCtD
Bicalutamide—Vomiting—Cisplatin—hematologic cancer	1.67e-05	7.35e-05	CcSEcCtD
Bicalutamide—Hyperhidrosis—Prednisone—hematologic cancer	1.67e-05	7.34e-05	CcSEcCtD
Bicalutamide—Mental disorder—Epirubicin—hematologic cancer	1.66e-05	7.32e-05	CcSEcCtD
Bicalutamide—Rash—Cisplatin—hematologic cancer	1.66e-05	7.29e-05	CcSEcCtD
Bicalutamide—Dermatitis—Cisplatin—hematologic cancer	1.66e-05	7.29e-05	CcSEcCtD
Bicalutamide—Malnutrition—Epirubicin—hematologic cancer	1.65e-05	7.28e-05	CcSEcCtD
Bicalutamide—Diarrhoea—Etoposide—hematologic cancer	1.65e-05	7.25e-05	CcSEcCtD
Bicalutamide—Anorexia—Prednisone—hematologic cancer	1.65e-05	7.24e-05	CcSEcCtD
Bicalutamide—Anaemia—Methotrexate—hematologic cancer	1.63e-05	7.19e-05	CcSEcCtD
Bicalutamide—Feeling abnormal—Dexamethasone—hematologic cancer	1.63e-05	7.19e-05	CcSEcCtD
Bicalutamide—Feeling abnormal—Betamethasone—hematologic cancer	1.63e-05	7.19e-05	CcSEcCtD
Bicalutamide—Cardiac disorder—Doxorubicin—hematologic cancer	1.63e-05	7.18e-05	CcSEcCtD
Bicalutamide—Flatulence—Epirubicin—hematologic cancer	1.63e-05	7.17e-05	CcSEcCtD
Bicalutamide—Tension—Epirubicin—hematologic cancer	1.62e-05	7.14e-05	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.62e-05	7.13e-05	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Betamethasone—hematologic cancer	1.62e-05	7.13e-05	CcSEcCtD
Bicalutamide—Hypersensitivity—Triamcinolone—hematologic cancer	1.61e-05	7.08e-05	CcSEcCtD
Bicalutamide—Nervousness—Epirubicin—hematologic cancer	1.61e-05	7.07e-05	CcSEcCtD
Bicalutamide—Back pain—Epirubicin—hematologic cancer	1.6e-05	7.04e-05	CcSEcCtD
Bicalutamide—Angiopathy—Doxorubicin—hematologic cancer	1.59e-05	7.02e-05	CcSEcCtD
Bicalutamide—Dizziness—Etoposide—hematologic cancer	1.59e-05	7.01e-05	CcSEcCtD
Bicalutamide—Muscle spasms—Epirubicin—hematologic cancer	1.59e-05	7e-05	CcSEcCtD
Bicalutamide—Immune system disorder—Doxorubicin—hematologic cancer	1.59e-05	6.99e-05	CcSEcCtD
Bicalutamide—Mediastinal disorder—Doxorubicin—hematologic cancer	1.58e-05	6.97e-05	CcSEcCtD
Bicalutamide—Chills—Doxorubicin—hematologic cancer	1.58e-05	6.94e-05	CcSEcCtD
Bicalutamide—Urticaria—Dexamethasone—hematologic cancer	1.57e-05	6.93e-05	CcSEcCtD
Bicalutamide—Urticaria—Betamethasone—hematologic cancer	1.57e-05	6.93e-05	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.57e-05	6.92e-05	CcSEcCtD
Bicalutamide—Dizziness—Prednisolone—hematologic cancer	1.57e-05	6.91e-05	CcSEcCtD
Bicalutamide—Arrhythmia—Doxorubicin—hematologic cancer	1.57e-05	6.91e-05	CcSEcCtD
Bicalutamide—Asthenia—Triamcinolone—hematologic cancer	1.57e-05	6.9e-05	CcSEcCtD
Bicalutamide—Abdominal pain—Dexamethasone—hematologic cancer	1.57e-05	6.89e-05	CcSEcCtD
Bicalutamide—Abdominal pain—Betamethasone—hematologic cancer	1.57e-05	6.89e-05	CcSEcCtD
Bicalutamide—Body temperature increased—Betamethasone—hematologic cancer	1.57e-05	6.89e-05	CcSEcCtD
Bicalutamide—Body temperature increased—Dexamethasone—hematologic cancer	1.57e-05	6.89e-05	CcSEcCtD
Bicalutamide—Nausea—Cisplatin—hematologic cancer	1.56e-05	6.87e-05	CcSEcCtD
Bicalutamide—Insomnia—Prednisone—hematologic cancer	1.56e-05	6.87e-05	CcSEcCtD
Bicalutamide—Alopecia—Doxorubicin—hematologic cancer	1.55e-05	6.84e-05	CcSEcCtD
Bicalutamide—Paraesthesia—Prednisone—hematologic cancer	1.55e-05	6.82e-05	CcSEcCtD
Bicalutamide—Pruritus—Triamcinolone—hematologic cancer	1.55e-05	6.8e-05	CcSEcCtD
Bicalutamide—Cough—Methotrexate—hematologic cancer	1.54e-05	6.79e-05	CcSEcCtD
Bicalutamide—Mental disorder—Doxorubicin—hematologic cancer	1.54e-05	6.78e-05	CcSEcCtD
Bicalutamide—Vomiting—Etoposide—hematologic cancer	1.53e-05	6.74e-05	CcSEcCtD
Bicalutamide—Malnutrition—Doxorubicin—hematologic cancer	1.53e-05	6.73e-05	CcSEcCtD
Bicalutamide—Anaemia—Epirubicin—hematologic cancer	1.53e-05	6.73e-05	CcSEcCtD
Bicalutamide—Dyspepsia—Prednisone—hematologic cancer	1.52e-05	6.69e-05	CcSEcCtD
Bicalutamide—Rash—Etoposide—hematologic cancer	1.52e-05	6.68e-05	CcSEcCtD
Bicalutamide—Dermatitis—Etoposide—hematologic cancer	1.52e-05	6.67e-05	CcSEcCtD
Bicalutamide—Headache—Etoposide—hematologic cancer	1.51e-05	6.64e-05	CcSEcCtD
Bicalutamide—Flatulence—Doxorubicin—hematologic cancer	1.51e-05	6.64e-05	CcSEcCtD
Bicalutamide—Myalgia—Methotrexate—hematologic cancer	1.5e-05	6.62e-05	CcSEcCtD
Bicalutamide—Chest pain—Methotrexate—hematologic cancer	1.5e-05	6.62e-05	CcSEcCtD
Bicalutamide—Tension—Doxorubicin—hematologic cancer	1.5e-05	6.61e-05	CcSEcCtD
Bicalutamide—Decreased appetite—Prednisone—hematologic cancer	1.5e-05	6.6e-05	CcSEcCtD
Bicalutamide—Rash—Prednisolone—hematologic cancer	1.5e-05	6.59e-05	CcSEcCtD
Bicalutamide—Dermatitis—Prednisolone—hematologic cancer	1.5e-05	6.58e-05	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.49e-05	6.58e-05	CcSEcCtD
Bicalutamide—Fatigue—Prednisone—hematologic cancer	1.49e-05	6.55e-05	CcSEcCtD
Bicalutamide—Headache—Prednisolone—hematologic cancer	1.49e-05	6.55e-05	CcSEcCtD
Bicalutamide—Nervousness—Doxorubicin—hematologic cancer	1.49e-05	6.54e-05	CcSEcCtD
Bicalutamide—Syncope—Epirubicin—hematologic cancer	1.48e-05	6.53e-05	CcSEcCtD
Bicalutamide—Back pain—Doxorubicin—hematologic cancer	1.48e-05	6.51e-05	CcSEcCtD
Bicalutamide—Constipation—Prednisone—hematologic cancer	1.48e-05	6.49e-05	CcSEcCtD
Bicalutamide—Muscle spasms—Doxorubicin—hematologic cancer	1.47e-05	6.47e-05	CcSEcCtD
Bicalutamide—Confusional state—Methotrexate—hematologic cancer	1.45e-05	6.4e-05	CcSEcCtD
Bicalutamide—Loss of consciousness—Epirubicin—hematologic cancer	1.45e-05	6.4e-05	CcSEcCtD
Bicalutamide—Dizziness—Triamcinolone—hematologic cancer	1.44e-05	6.36e-05	CcSEcCtD
Bicalutamide—Cough—Epirubicin—hematologic cancer	1.44e-05	6.35e-05	CcSEcCtD
Bicalutamide—Infection—Methotrexate—hematologic cancer	1.43e-05	6.31e-05	CcSEcCtD
Bicalutamide—Nausea—Etoposide—hematologic cancer	1.43e-05	6.29e-05	CcSEcCtD
Bicalutamide—Hypertension—Epirubicin—hematologic cancer	1.43e-05	6.28e-05	CcSEcCtD
Bicalutamide—Feeling abnormal—Prednisone—hematologic cancer	1.42e-05	6.26e-05	CcSEcCtD
Bicalutamide—Asthenia—Dexamethasone—hematologic cancer	1.42e-05	6.26e-05	CcSEcCtD
Bicalutamide—Asthenia—Betamethasone—hematologic cancer	1.42e-05	6.26e-05	CcSEcCtD
Bicalutamide—Nervous system disorder—Methotrexate—hematologic cancer	1.41e-05	6.22e-05	CcSEcCtD
Bicalutamide—Anaemia—Doxorubicin—hematologic cancer	1.41e-05	6.22e-05	CcSEcCtD
Bicalutamide—Thrombocytopenia—Methotrexate—hematologic cancer	1.41e-05	6.21e-05	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Prednisone—hematologic cancer	1.41e-05	6.21e-05	CcSEcCtD
Bicalutamide—Nausea—Prednisolone—hematologic cancer	1.41e-05	6.21e-05	CcSEcCtD
Bicalutamide—Chest pain—Epirubicin—hematologic cancer	1.41e-05	6.2e-05	CcSEcCtD
Bicalutamide—Myalgia—Epirubicin—hematologic cancer	1.41e-05	6.2e-05	CcSEcCtD
Bicalutamide—Anxiety—Epirubicin—hematologic cancer	1.4e-05	6.17e-05	CcSEcCtD
Bicalutamide—Pruritus—Betamethasone—hematologic cancer	1.4e-05	6.17e-05	CcSEcCtD
Bicalutamide—Pruritus—Dexamethasone—hematologic cancer	1.4e-05	6.17e-05	CcSEcCtD
Bicalutamide—Skin disorder—Methotrexate—hematologic cancer	1.4e-05	6.17e-05	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.4e-05	6.15e-05	CcSEcCtD
Bicalutamide—Hyperhidrosis—Methotrexate—hematologic cancer	1.39e-05	6.14e-05	CcSEcCtD
Bicalutamide—Vomiting—Triamcinolone—hematologic cancer	1.39e-05	6.11e-05	CcSEcCtD
Bicalutamide—CYP2D6—Metabolism—ASNS—hematologic cancer	1.38e-05	0.00033	CbGpPWpGaD
Bicalutamide—Rash—Triamcinolone—hematologic cancer	1.38e-05	6.06e-05	CcSEcCtD
Bicalutamide—Dry mouth—Epirubicin—hematologic cancer	1.38e-05	6.06e-05	CcSEcCtD
Bicalutamide—Dermatitis—Triamcinolone—hematologic cancer	1.38e-05	6.05e-05	CcSEcCtD
Bicalutamide—Anorexia—Methotrexate—hematologic cancer	1.37e-05	6.05e-05	CcSEcCtD
Bicalutamide—Syncope—Doxorubicin—hematologic cancer	1.37e-05	6.04e-05	CcSEcCtD
Bicalutamide—Urticaria—Prednisone—hematologic cancer	1.37e-05	6.03e-05	CcSEcCtD
Bicalutamide—CYP2C9—Metabolism—B3GAT1—hematologic cancer	1.37e-05	0.000327	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—DCK—hematologic cancer	1.37e-05	0.000327	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ASNS—hematologic cancer	1.37e-05	0.000327	CbGpPWpGaD
Bicalutamide—Headache—Triamcinolone—hematologic cancer	1.37e-05	6.02e-05	CcSEcCtD
Bicalutamide—Body temperature increased—Prednisone—hematologic cancer	1.36e-05	6e-05	CcSEcCtD
Bicalutamide—Abdominal pain—Prednisone—hematologic cancer	1.36e-05	6e-05	CcSEcCtD
Bicalutamide—Confusional state—Epirubicin—hematologic cancer	1.36e-05	5.99e-05	CcSEcCtD
Bicalutamide—Diarrhoea—Betamethasone—hematologic cancer	1.36e-05	5.97e-05	CcSEcCtD
Bicalutamide—Diarrhoea—Dexamethasone—hematologic cancer	1.36e-05	5.97e-05	CcSEcCtD
Bicalutamide—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.36e-05	0.000324	CbGpPWpGaD
Bicalutamide—Oedema—Epirubicin—hematologic cancer	1.35e-05	5.94e-05	CcSEcCtD
Bicalutamide—Loss of consciousness—Doxorubicin—hematologic cancer	1.34e-05	5.92e-05	CcSEcCtD
Bicalutamide—Infection—Epirubicin—hematologic cancer	1.34e-05	5.9e-05	CcSEcCtD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.34e-05	0.00032	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.34e-05	0.000319	CbGpPWpGaD
Bicalutamide—Cough—Doxorubicin—hematologic cancer	1.34e-05	5.88e-05	CcSEcCtD
Bicalutamide—Shock—Epirubicin—hematologic cancer	1.33e-05	5.84e-05	CcSEcCtD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.33e-05	0.000317	CbGpPWpGaD
Bicalutamide—Nervous system disorder—Epirubicin—hematologic cancer	1.32e-05	5.82e-05	CcSEcCtD
Bicalutamide—Thrombocytopenia—Epirubicin—hematologic cancer	1.32e-05	5.82e-05	CcSEcCtD
Bicalutamide—Hypertension—Doxorubicin—hematologic cancer	1.32e-05	5.81e-05	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.31e-05	5.78e-05	CcSEcCtD
Bicalutamide—Skin disorder—Epirubicin—hematologic cancer	1.31e-05	5.77e-05	CcSEcCtD
Bicalutamide—Dizziness—Betamethasone—hematologic cancer	1.31e-05	5.77e-05	CcSEcCtD
Bicalutamide—Dizziness—Dexamethasone—hematologic cancer	1.31e-05	5.77e-05	CcSEcCtD
Bicalutamide—CYP2D6—Metabolism—HDC—hematologic cancer	1.31e-05	0.000313	CbGpPWpGaD
Bicalutamide—Hyperhidrosis—Epirubicin—hematologic cancer	1.3e-05	5.74e-05	CcSEcCtD
Bicalutamide—Insomnia—Methotrexate—hematologic cancer	1.3e-05	5.74e-05	CcSEcCtD
Bicalutamide—Chest pain—Doxorubicin—hematologic cancer	1.3e-05	5.73e-05	CcSEcCtD
Bicalutamide—Myalgia—Doxorubicin—hematologic cancer	1.3e-05	5.73e-05	CcSEcCtD
Bicalutamide—CYP2C19—Metabolism—CDA—hematologic cancer	1.3e-05	0.000311	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HDC—hematologic cancer	1.3e-05	0.00031	CbGpPWpGaD
Bicalutamide—Anxiety—Doxorubicin—hematologic cancer	1.3e-05	5.71e-05	CcSEcCtD
Bicalutamide—Nausea—Triamcinolone—hematologic cancer	1.3e-05	5.71e-05	CcSEcCtD
Bicalutamide—Paraesthesia—Methotrexate—hematologic cancer	1.3e-05	5.7e-05	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.29e-05	5.69e-05	CcSEcCtD
Bicalutamide—Anorexia—Epirubicin—hematologic cancer	1.29e-05	5.66e-05	CcSEcCtD
Bicalutamide—Dyspnoea—Methotrexate—hematologic cancer	1.29e-05	5.66e-05	CcSEcCtD
Bicalutamide—Somnolence—Methotrexate—hematologic cancer	1.28e-05	5.64e-05	CcSEcCtD
Bicalutamide—Dry mouth—Doxorubicin—hematologic cancer	1.27e-05	5.61e-05	CcSEcCtD
Bicalutamide—Hypersensitivity—Prednisone—hematologic cancer	1.27e-05	5.6e-05	CcSEcCtD
Bicalutamide—Dyspepsia—Methotrexate—hematologic cancer	1.27e-05	5.59e-05	CcSEcCtD
Bicalutamide—Vomiting—Betamethasone—hematologic cancer	1.26e-05	5.54e-05	CcSEcCtD
Bicalutamide—Vomiting—Dexamethasone—hematologic cancer	1.26e-05	5.54e-05	CcSEcCtD
Bicalutamide—Confusional state—Doxorubicin—hematologic cancer	1.26e-05	5.54e-05	CcSEcCtD
Bicalutamide—Decreased appetite—Methotrexate—hematologic cancer	1.25e-05	5.52e-05	CcSEcCtD
Bicalutamide—CYP2C19—Metabolism—PC—hematologic cancer	1.25e-05	0.0003	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—CDKN2B—hematologic cancer	1.25e-05	0.000299	CbGpPWpGaD
Bicalutamide—Rash—Betamethasone—hematologic cancer	1.25e-05	5.5e-05	CcSEcCtD
Bicalutamide—Rash—Dexamethasone—hematologic cancer	1.25e-05	5.5e-05	CcSEcCtD
Bicalutamide—Oedema—Doxorubicin—hematologic cancer	1.25e-05	5.5e-05	CcSEcCtD
Bicalutamide—Dermatitis—Dexamethasone—hematologic cancer	1.25e-05	5.49e-05	CcSEcCtD
Bicalutamide—Dermatitis—Betamethasone—hematologic cancer	1.25e-05	5.49e-05	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.25e-05	5.48e-05	CcSEcCtD
Bicalutamide—Fatigue—Methotrexate—hematologic cancer	1.24e-05	5.47e-05	CcSEcCtD
Bicalutamide—Headache—Dexamethasone—hematologic cancer	1.24e-05	5.46e-05	CcSEcCtD
Bicalutamide—Headache—Betamethasone—hematologic cancer	1.24e-05	5.46e-05	CcSEcCtD
Bicalutamide—Infection—Doxorubicin—hematologic cancer	1.24e-05	5.46e-05	CcSEcCtD
Bicalutamide—Asthenia—Prednisone—hematologic cancer	1.24e-05	5.45e-05	CcSEcCtD
Bicalutamide—Pain—Methotrexate—hematologic cancer	1.23e-05	5.43e-05	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.23e-05	5.41e-05	CcSEcCtD
Bicalutamide—Shock—Doxorubicin—hematologic cancer	1.23e-05	5.41e-05	CcSEcCtD
Bicalutamide—Nervous system disorder—Doxorubicin—hematologic cancer	1.22e-05	5.39e-05	CcSEcCtD
Bicalutamide—Thrombocytopenia—Doxorubicin—hematologic cancer	1.22e-05	5.38e-05	CcSEcCtD
Bicalutamide—Pruritus—Prednisone—hematologic cancer	1.22e-05	5.37e-05	CcSEcCtD
Bicalutamide—Insomnia—Epirubicin—hematologic cancer	1.22e-05	5.37e-05	CcSEcCtD
Bicalutamide—Skin disorder—Doxorubicin—hematologic cancer	1.21e-05	5.34e-05	CcSEcCtD
Bicalutamide—Paraesthesia—Epirubicin—hematologic cancer	1.21e-05	5.33e-05	CcSEcCtD
Bicalutamide—CYP2C19—Metabolism—GBA—hematologic cancer	1.21e-05	0.000289	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SLC35B2—hematologic cancer	1.21e-05	0.000289	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.21e-05	0.000289	CbGpPWpGaD
Bicalutamide—Hyperhidrosis—Doxorubicin—hematologic cancer	1.21e-05	5.31e-05	CcSEcCtD
Bicalutamide—Dyspnoea—Epirubicin—hematologic cancer	1.2e-05	5.3e-05	CcSEcCtD
Bicalutamide—Somnolence—Epirubicin—hematologic cancer	1.2e-05	5.28e-05	CcSEcCtD
Bicalutamide—CYP2D6—Metabolism—CDA—hematologic cancer	1.2e-05	0.000286	CbGpPWpGaD
Bicalutamide—Anorexia—Doxorubicin—hematologic cancer	1.19e-05	5.24e-05	CcSEcCtD
Bicalutamide—Feeling abnormal—Methotrexate—hematologic cancer	1.19e-05	5.23e-05	CcSEcCtD
Bicalutamide—Dyspepsia—Epirubicin—hematologic cancer	1.19e-05	5.23e-05	CcSEcCtD
Bicalutamide—CYP2C9—Metabolism—CDA—hematologic cancer	1.19e-05	0.000284	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—NCOR1—hematologic cancer	1.19e-05	0.000284	CbGpPWpGaD
Bicalutamide—Diarrhoea—Prednisone—hematologic cancer	1.18e-05	5.2e-05	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Methotrexate—hematologic cancer	1.18e-05	5.19e-05	CcSEcCtD
Bicalutamide—Nausea—Betamethasone—hematologic cancer	1.18e-05	5.18e-05	CcSEcCtD
Bicalutamide—Nausea—Dexamethasone—hematologic cancer	1.18e-05	5.18e-05	CcSEcCtD
Bicalutamide—Decreased appetite—Epirubicin—hematologic cancer	1.17e-05	5.16e-05	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.17e-05	5.13e-05	CcSEcCtD
Bicalutamide—Fatigue—Epirubicin—hematologic cancer	1.16e-05	5.12e-05	CcSEcCtD
Bicalutamide—Pain—Epirubicin—hematologic cancer	1.15e-05	5.08e-05	CcSEcCtD
Bicalutamide—Constipation—Epirubicin—hematologic cancer	1.15e-05	5.08e-05	CcSEcCtD
Bicalutamide—CYP2D6—Metabolism—PC—hematologic cancer	1.15e-05	0.000275	CbGpPWpGaD
Bicalutamide—Urticaria—Methotrexate—hematologic cancer	1.15e-05	5.04e-05	CcSEcCtD
Bicalutamide—CYP2C9—Metabolism—PC—hematologic cancer	1.14e-05	0.000273	CbGpPWpGaD
Bicalutamide—Dizziness—Prednisone—hematologic cancer	1.14e-05	5.02e-05	CcSEcCtD
Bicalutamide—Abdominal pain—Methotrexate—hematologic cancer	1.14e-05	5.02e-05	CcSEcCtD
Bicalutamide—Body temperature increased—Methotrexate—hematologic cancer	1.14e-05	5.02e-05	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.14e-05	5.01e-05	CcSEcCtD
Bicalutamide—CYP3A4—Metabolism—FTCD—hematologic cancer	1.13e-05	0.00027	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PHYH—hematologic cancer	1.13e-05	0.00027	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GMPS—hematologic cancer	1.13e-05	0.00027	CbGpPWpGaD
Bicalutamide—Insomnia—Doxorubicin—hematologic cancer	1.13e-05	4.97e-05	CcSEcCtD
Bicalutamide—Paraesthesia—Doxorubicin—hematologic cancer	1.12e-05	4.94e-05	CcSEcCtD
Bicalutamide—CYP2D6—Metabolism—GBA—hematologic cancer	1.11e-05	0.000266	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SLC35B2—hematologic cancer	1.11e-05	0.000266	CbGpPWpGaD
Bicalutamide—Dyspnoea—Doxorubicin—hematologic cancer	1.11e-05	4.9e-05	CcSEcCtD
Bicalutamide—Feeling abnormal—Epirubicin—hematologic cancer	1.11e-05	4.89e-05	CcSEcCtD
Bicalutamide—Somnolence—Doxorubicin—hematologic cancer	1.11e-05	4.89e-05	CcSEcCtD
Bicalutamide—CYP2C19—Metabolism—MTAP—hematologic cancer	1.11e-05	0.000265	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GBA—hematologic cancer	1.1e-05	0.000264	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SLC35B2—hematologic cancer	1.1e-05	0.000264	CbGpPWpGaD
Bicalutamide—Gastrointestinal pain—Epirubicin—hematologic cancer	1.1e-05	4.86e-05	CcSEcCtD
Bicalutamide—Dyspepsia—Doxorubicin—hematologic cancer	1.1e-05	4.84e-05	CcSEcCtD
Bicalutamide—AR—Gene Expression—NR3C1—hematologic cancer	1.1e-05	0.000262	CbGpPWpGaD
Bicalutamide—Vomiting—Prednisone—hematologic cancer	1.1e-05	4.83e-05	CcSEcCtD
Bicalutamide—Rash—Prednisone—hematologic cancer	1.09e-05	4.79e-05	CcSEcCtD
Bicalutamide—Dermatitis—Prednisone—hematologic cancer	1.09e-05	4.78e-05	CcSEcCtD
Bicalutamide—Decreased appetite—Doxorubicin—hematologic cancer	1.09e-05	4.78e-05	CcSEcCtD
Bicalutamide—Headache—Prednisone—hematologic cancer	1.08e-05	4.76e-05	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.08e-05	4.74e-05	CcSEcCtD
Bicalutamide—Fatigue—Doxorubicin—hematologic cancer	1.08e-05	4.74e-05	CcSEcCtD
Bicalutamide—Urticaria—Epirubicin—hematologic cancer	1.07e-05	4.72e-05	CcSEcCtD
Bicalutamide—Pain—Doxorubicin—hematologic cancer	1.07e-05	4.7e-05	CcSEcCtD
Bicalutamide—Constipation—Doxorubicin—hematologic cancer	1.07e-05	4.7e-05	CcSEcCtD
Bicalutamide—Abdominal pain—Epirubicin—hematologic cancer	1.07e-05	4.7e-05	CcSEcCtD
Bicalutamide—Body temperature increased—Epirubicin—hematologic cancer	1.07e-05	4.7e-05	CcSEcCtD
Bicalutamide—Hypersensitivity—Methotrexate—hematologic cancer	1.06e-05	4.68e-05	CcSEcCtD
Bicalutamide—Asthenia—Methotrexate—hematologic cancer	1.03e-05	4.55e-05	CcSEcCtD
Bicalutamide—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.03e-05	0.000247	CbGpPWpGaD
Bicalutamide—Feeling abnormal—Doxorubicin—hematologic cancer	1.03e-05	4.53e-05	CcSEcCtD
Bicalutamide—Nausea—Prednisone—hematologic cancer	1.03e-05	4.51e-05	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.02e-05	4.49e-05	CcSEcCtD
Bicalutamide—Pruritus—Methotrexate—hematologic cancer	1.02e-05	4.49e-05	CcSEcCtD
Bicalutamide—CYP2D6—Metabolism—MTAP—hematologic cancer	1.02e-05	0.000243	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MTAP—hematologic cancer	1.01e-05	0.000241	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—MYC—hematologic cancer	1.01e-05	0.000241	CbGpPWpGaD
Bicalutamide—Hypersensitivity—Epirubicin—hematologic cancer	9.94e-06	4.38e-05	CcSEcCtD
Bicalutamide—Urticaria—Doxorubicin—hematologic cancer	9.92e-06	4.37e-05	CcSEcCtD
Bicalutamide—Abdominal pain—Doxorubicin—hematologic cancer	9.87e-06	4.34e-05	CcSEcCtD
Bicalutamide—Body temperature increased—Doxorubicin—hematologic cancer	9.87e-06	4.34e-05	CcSEcCtD
Bicalutamide—CYP2C19—Metabolism—FHL2—hematologic cancer	9.87e-06	0.000236	CbGpPWpGaD
Bicalutamide—Diarrhoea—Methotrexate—hematologic cancer	9.87e-06	4.34e-05	CcSEcCtD
Bicalutamide—Asthenia—Epirubicin—hematologic cancer	9.68e-06	4.26e-05	CcSEcCtD
Bicalutamide—CYP2C19—Metabolism—AGRN—hematologic cancer	9.68e-06	0.000231	CbGpPWpGaD
Bicalutamide—Pruritus—Epirubicin—hematologic cancer	9.55e-06	4.2e-05	CcSEcCtD
Bicalutamide—Dizziness—Methotrexate—hematologic cancer	9.54e-06	4.2e-05	CcSEcCtD
Bicalutamide—AR—Gene Expression—MAPK14—hematologic cancer	9.5e-06	0.000227	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—ESR1—hematologic cancer	9.32e-06	0.000223	CbGpPWpGaD
Bicalutamide—Diarrhoea—Epirubicin—hematologic cancer	9.23e-06	4.06e-05	CcSEcCtD
Bicalutamide—Hypersensitivity—Doxorubicin—hematologic cancer	9.2e-06	4.05e-05	CcSEcCtD
Bicalutamide—CYP2C19—Metabolism—HMMR—hematologic cancer	9.18e-06	0.000219	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—IDH2—hematologic cancer	9.18e-06	0.000219	CbGpPWpGaD
Bicalutamide—Vomiting—Methotrexate—hematologic cancer	9.17e-06	4.04e-05	CcSEcCtD
Bicalutamide—Rash—Methotrexate—hematologic cancer	9.09e-06	4e-05	CcSEcCtD
Bicalutamide—Dermatitis—Methotrexate—hematologic cancer	9.09e-06	4e-05	CcSEcCtD
Bicalutamide—CYP2D6—Metabolism—FHL2—hematologic cancer	9.08e-06	0.000217	CbGpPWpGaD
Bicalutamide—Headache—Methotrexate—hematologic cancer	9.04e-06	3.98e-05	CcSEcCtD
Bicalutamide—CYP3A4—Metabolism—B3GAT1—hematologic cancer	9.03e-06	0.000216	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ASNS—hematologic cancer	9.03e-06	0.000216	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—DCK—hematologic cancer	9.03e-06	0.000216	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—NOTCH1—hematologic cancer	9.01e-06	0.000215	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—FHL2—hematologic cancer	9e-06	0.000215	CbGpPWpGaD
Bicalutamide—Asthenia—Doxorubicin—hematologic cancer	8.96e-06	3.94e-05	CcSEcCtD
Bicalutamide—Dizziness—Epirubicin—hematologic cancer	8.93e-06	3.93e-05	CcSEcCtD
Bicalutamide—CYP2D6—Metabolism—AGRN—hematologic cancer	8.9e-06	0.000213	CbGpPWpGaD
Bicalutamide—Pruritus—Doxorubicin—hematologic cancer	8.84e-06	3.89e-05	CcSEcCtD
Bicalutamide—CYP2C9—Metabolism—AGRN—hematologic cancer	8.83e-06	0.000211	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.65e-06	0.000207	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ARNTL—hematologic cancer	8.63e-06	0.000206	CbGpPWpGaD
Bicalutamide—Vomiting—Epirubicin—hematologic cancer	8.58e-06	3.78e-05	CcSEcCtD
Bicalutamide—Nausea—Methotrexate—hematologic cancer	8.57e-06	3.77e-05	CcSEcCtD
Bicalutamide—CYP3A4—Metabolism—HDC—hematologic cancer	8.56e-06	0.000205	CbGpPWpGaD
Bicalutamide—Diarrhoea—Doxorubicin—hematologic cancer	8.54e-06	3.76e-05	CcSEcCtD
Bicalutamide—Rash—Epirubicin—hematologic cancer	8.51e-06	3.75e-05	CcSEcCtD
Bicalutamide—Dermatitis—Epirubicin—hematologic cancer	8.5e-06	3.74e-05	CcSEcCtD
Bicalutamide—Headache—Epirubicin—hematologic cancer	8.46e-06	3.72e-05	CcSEcCtD
Bicalutamide—CYP2D6—Metabolism—IDH2—hematologic cancer	8.44e-06	0.000202	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HMMR—hematologic cancer	8.44e-06	0.000202	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ACP5—hematologic cancer	8.39e-06	0.000201	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CA9—hematologic cancer	8.39e-06	0.000201	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—IDH2—hematologic cancer	8.37e-06	0.0002	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HMMR—hematologic cancer	8.37e-06	0.0002	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NCOR2—hematologic cancer	8.28e-06	0.000198	CbGpPWpGaD
Bicalutamide—Dizziness—Doxorubicin—hematologic cancer	8.26e-06	3.63e-05	CcSEcCtD
Bicalutamide—AR—Gene Expression—CREBBP—hematologic cancer	8.17e-06	0.000195	CbGpPWpGaD
Bicalutamide—Nausea—Epirubicin—hematologic cancer	8.02e-06	3.53e-05	CcSEcCtD
Bicalutamide—Vomiting—Doxorubicin—hematologic cancer	7.94e-06	3.49e-05	CcSEcCtD
Bicalutamide—CYP2D6—Metabolism—ARNTL—hematologic cancer	7.94e-06	0.00019	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—IDH1—hematologic cancer	7.89e-06	0.000189	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	7.89e-06	0.000189	CbGpPWpGaD
Bicalutamide—Rash—Doxorubicin—hematologic cancer	7.87e-06	3.47e-05	CcSEcCtD
Bicalutamide—Dermatitis—Doxorubicin—hematologic cancer	7.87e-06	3.46e-05	CcSEcCtD
Bicalutamide—CYP2C9—Metabolism—ARNTL—hematologic cancer	7.87e-06	0.000188	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CDA—hematologic cancer	7.83e-06	0.000187	CbGpPWpGaD
Bicalutamide—Headache—Doxorubicin—hematologic cancer	7.82e-06	3.44e-05	CcSEcCtD
Bicalutamide—CYP2C19—Metabolism—ABCC3—hematologic cancer	7.8e-06	0.000186	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—TXN—hematologic cancer	7.8e-06	0.000186	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTO1—hematologic cancer	7.8e-06	0.000186	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CA9—hematologic cancer	7.72e-06	0.000184	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ACP5—hematologic cancer	7.72e-06	0.000184	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ACP5—hematologic cancer	7.65e-06	0.000183	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CA9—hematologic cancer	7.65e-06	0.000183	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SPHK1—hematologic cancer	7.64e-06	0.000182	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NCOR2—hematologic cancer	7.62e-06	0.000182	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NCOR2—hematologic cancer	7.55e-06	0.00018	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PC—hematologic cancer	7.54e-06	0.00018	CbGpPWpGaD
Bicalutamide—Nausea—Doxorubicin—hematologic cancer	7.42e-06	3.26e-05	CcSEcCtD
Bicalutamide—CYP2C19—Metabolism—UGT1A1—hematologic cancer	7.34e-06	0.000175	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLC35B2—hematologic cancer	7.28e-06	0.000174	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GBA—hematologic cancer	7.28e-06	0.000174	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—IDH1—hematologic cancer	7.26e-06	0.000173	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—IDH1—hematologic cancer	7.19e-06	0.000172	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTO1—hematologic cancer	7.18e-06	0.000171	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—TXN—hematologic cancer	7.18e-06	0.000171	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ABCC3—hematologic cancer	7.18e-06	0.000171	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CRABP1—hematologic cancer	7.14e-06	0.00017	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SLC22A1—hematologic cancer	7.14e-06	0.00017	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTO1—hematologic cancer	7.11e-06	0.00017	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—TXN—hematologic cancer	7.11e-06	0.00017	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ABCC3—hematologic cancer	7.11e-06	0.00017	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SPHK1—hematologic cancer	7.02e-06	0.000168	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SPHK1—hematologic cancer	6.96e-06	0.000166	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALOX5—hematologic cancer	6.95e-06	0.000166	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—UGT1A1—hematologic cancer	6.75e-06	0.000161	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NUP98—hematologic cancer	6.74e-06	0.000161	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—UGT1A1—hematologic cancer	6.69e-06	0.00016	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MTAP—hematologic cancer	6.66e-06	0.000159	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SLC22A1—hematologic cancer	6.56e-06	0.000157	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CRABP1—hematologic cancer	6.56e-06	0.000157	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NCOA3—hematologic cancer	6.54e-06	0.000156	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ADCY7—hematologic cancer	6.54e-06	0.000156	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CRABP1—hematologic cancer	6.51e-06	0.000155	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SLC22A1—hematologic cancer	6.51e-06	0.000155	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NUP214—hematologic cancer	6.49e-06	0.000155	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.42e-06	0.000154	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALOX5—hematologic cancer	6.4e-06	0.000153	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—MTR—hematologic cancer	6.36e-06	0.000152	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ABCG2—hematologic cancer	6.36e-06	0.000152	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALOX5—hematologic cancer	6.34e-06	0.000151	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ENO2—hematologic cancer	6.24e-06	0.000149	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NUP98—hematologic cancer	6.19e-06	0.000148	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NUP98—hematologic cancer	6.14e-06	0.000147	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTT1—hematologic cancer	6.05e-06	0.000145	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ADCY7—hematologic cancer	6.01e-06	0.000144	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NCOA3—hematologic cancer	6.01e-06	0.000144	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NUP214—hematologic cancer	5.97e-06	0.000143	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ADCY7—hematologic cancer	5.96e-06	0.000142	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NCOA3—hematologic cancer	5.96e-06	0.000142	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.96e-06	0.000142	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—FHL2—hematologic cancer	5.94e-06	0.000142	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NUP214—hematologic cancer	5.92e-06	0.000141	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SDC1—hematologic cancer	5.91e-06	0.000141	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.86e-06	0.00014	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—MTR—hematologic cancer	5.85e-06	0.00014	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ABCG2—hematologic cancer	5.85e-06	0.00014	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—AGRN—hematologic cancer	5.82e-06	0.000139	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MTR—hematologic cancer	5.8e-06	0.000139	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ABCG2—hematologic cancer	5.8e-06	0.000139	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ENO2—hematologic cancer	5.74e-06	0.000137	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ENO2—hematologic cancer	5.69e-06	0.000136	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.65e-06	0.000135	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.58e-06	0.000133	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTT1—hematologic cancer	5.56e-06	0.000133	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—IDH2—hematologic cancer	5.52e-06	0.000132	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HMMR—hematologic cancer	5.52e-06	0.000132	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTT1—hematologic cancer	5.52e-06	0.000132	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SDC1—hematologic cancer	5.44e-06	0.00013	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.43e-06	0.00013	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SDC1—hematologic cancer	5.39e-06	0.000129	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.33e-06	0.000127	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.19e-06	0.000124	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.15e-06	0.000123	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.08e-06	0.000121	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CA9—hematologic cancer	5.05e-06	0.000121	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ACP5—hematologic cancer	5.05e-06	0.000121	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NQO1—hematologic cancer	5.03e-06	0.00012	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CD44—hematologic cancer	5.03e-06	0.00012	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—MAPK3—hematologic cancer	4.99e-06	0.000119	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.98e-06	0.000119	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.92e-06	0.000118	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.86e-06	0.000116	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—MYC—hematologic cancer	4.85e-06	0.000116	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYCS—hematologic cancer	4.76e-06	0.000114	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—IDH1—hematologic cancer	4.75e-06	0.000113	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	4.73e-06	0.000113	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.69e-06	0.000112	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.69e-06	0.000112	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—TXN—hematologic cancer	4.69e-06	0.000112	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CD44—hematologic cancer	4.62e-06	0.00011	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NQO1—hematologic cancer	4.62e-06	0.00011	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.59e-06	0.00011	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NQO1—hematologic cancer	4.58e-06	0.00011	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CD44—hematologic cancer	4.58e-06	0.00011	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.49e-06	0.000107	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.41e-06	0.000105	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYCS—hematologic cancer	4.38e-06	0.000105	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	4.35e-06	0.000104	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYCS—hematologic cancer	4.34e-06	0.000104	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	4.31e-06	0.000103	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.29e-06	0.000103	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.29e-06	0.000103	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.25e-06	0.000102	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTP1—hematologic cancer	4.19e-06	0.0001	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.18e-06	9.99e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.06e-06	9.69e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NUP98—hematologic cancer	4.05e-06	9.68e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ABCB1—hematologic cancer	3.97e-06	9.48e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.93e-06	9.39e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.93e-06	9.39e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NUP214—hematologic cancer	3.9e-06	9.33e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.88e-06	9.27e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTP1—hematologic cancer	3.86e-06	9.21e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTM1—hematologic cancer	3.85e-06	9.21e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NCOR1—hematologic cancer	3.85e-06	9.21e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.82e-06	9.14e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MTR—hematologic cancer	3.82e-06	9.14e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.82e-06	9.14e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ENO2—hematologic cancer	3.75e-06	8.96e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.7e-06	8.84e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.65e-06	8.72e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.64e-06	8.69e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.62e-06	8.65e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SDC1—hematologic cancer	3.56e-06	8.5e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.54e-06	8.47e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.54e-06	8.47e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.51e-06	8.39e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.51e-06	8.39e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—MTHFR—hematologic cancer	3.41e-06	8.14e-05	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—AKT1—hematologic cancer	3.36e-06	8.03e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.13e-06	7.48e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.11e-06	7.42e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NQO1—hematologic cancer	3.02e-06	7.22e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CD44—hematologic cancer	3.02e-06	7.22e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3e-06	7.17e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.86e-06	6.84e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYCS—hematologic cancer	2.86e-06	6.84e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.84e-06	6.79e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.74e-06	6.54e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.65e-06	6.34e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.63e-06	6.29e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.61e-06	6.23e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.52e-06	6.02e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.52e-06	6.01e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALB—hematologic cancer	2.48e-06	5.93e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.44e-06	5.83e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.42e-06	5.78e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.39e-06	5.7e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.38e-06	5.68e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.32e-06	5.54e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.32e-06	5.54e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.31e-06	5.53e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.29e-06	5.48e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALB—hematologic cancer	2.28e-06	5.46e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALB—hematologic cancer	2.26e-06	5.41e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.19e-06	5.24e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.18e-06	5.22e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.17e-06	5.17e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.05e-06	4.89e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.02e-06	4.82e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2e-06	4.78e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTEN—hematologic cancer	1.89e-06	4.53e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—EP300—hematologic cancer	1.81e-06	4.32e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTEN—hematologic cancer	1.74e-06	4.16e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTEN—hematologic cancer	1.73e-06	4.13e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.72e-06	4.11e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—EP300—hematologic cancer	1.66e-06	3.97e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—EP300—hematologic cancer	1.65e-06	3.94e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.6e-06	3.81e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.51e-06	3.61e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALB—hematologic cancer	1.49e-06	3.57e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.43e-06	3.41e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.34e-06	3.19e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.32e-06	3.15e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.23e-06	2.94e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.22e-06	2.91e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTEN—hematologic cancer	1.14e-06	2.72e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—AKT1—hematologic cancer	1.09e-06	2.61e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—EP300—hematologic cancer	1.09e-06	2.6e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—AKT1—hematologic cancer	1e-06	2.4e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—AKT1—hematologic cancer	9.96e-07	2.38e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	8.04e-07	1.92e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—AKT1—hematologic cancer	6.57e-07	1.57e-05	CbGpPWpGaD
